The secondary aim is to examine if there is any difference in the incidence of PMPS among patients who underwent BCS categorised further as BCS alone (Group-B), BCS plus sentinel lymph node biopsy (Group-BS) and BCS plus axillary lymph node clearance (Group-BA).